Department of Cardiology, Aalborg AF Study Group, Aarhus University Hospital, Aalborg, Denmark.
Curr Opin Clin Nutr Metab Care. 2013 Mar;16(2):168-73. doi: 10.1097/MCO.0b013e32835bf39b.
There are suggestions of effects of marine omega-3 polyunsaturated fatty acids (PUFAs) in relation to ventricular arrhythmia and sudden cardiac death and, more recently, also of possible effects related to atrial fibrillation.
On the basis of the recently published human studies, this article not only focusses primarily on recent developments and current knowledge on the effect of marine omega-3 PUFAs on atrial fibrillation, but also provides a status for their effects on ventricular arrhythmias.
Marine omega-3 PUFAs may protect against ventricular arrhythmias, and there is growing evidence for an effect of marine omega-3 PUFAs in the prevention and treatment of atrial fibrillation. Further studies are needed to establish which patients are more likely to benefit from omega-3 PUFAs, the timing of treatment, and the dosages.
有研究提示海洋 ω-3 多不饱和脂肪酸(PUFAs)与室性心律失常和心源性猝死有关,最近还有研究提示其与心房颤动可能相关。
基于最近发表的人体研究,本文不仅主要关注海洋 ω-3 PUFAs 对心房颤动影响的最新进展和现有知识,还介绍了其对室性心律失常影响的现状。
海洋 ω-3 PUFAs 可能对室性心律失常有保护作用,并且越来越多的证据表明海洋 ω-3 PUFAs 可预防和治疗心房颤动。需要进一步的研究来确定哪些患者更可能从 ω-3 PUFAs 中获益、治疗时机和剂量。